Bacteriophages Therapy Market, By Target (Escherichia Coli, Staphylococcus, Streptococcus, Pseudomonas, Salmonella, Others),Trends

Antibiotic resistance is becoming more common worldwide, which is driving up demand for effective alternatives. According to the CDC, antibiotic-resistant bacterial infections affect approximately 33 000 people in Europe each year. Antibiotic resistance is predicted to increase globally, creating considerable demand for bacteriophages. Phage therapy is another name for bacteriophage therapy. In order to treat bacterial infections, viruses are used. Bacteriophages are bacterial viruses. Phages are bacteria-killing viruses that are harmless to plants, animals, and humans. Bacteriophages are thought to be bacteria's natural adversaries. Bacteriophages can be found in sewage, water, soil, and other environments where bacteria exist.

View Detailed Report: https://www.databridgemarketresearch.com/reports/global-bacteriophages-therapy-market

Data Bridge Market Research analyses that the bacteriophages therapy market was valued at USD 39.80 million in 2021 and is expected to reach USD 64.40 million by 2029, registering a CAGR of 6.20% during the forecast period of 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Bacteriophages, are viruses that kill and target bacteria exclusively. They're one of the most frequent biological entities capable of fighting and killing multidrug-resistant bacteria. When all other antibiotics have failed to treat an infection, phages can eliminate the bacteria causing the infection, allowing medical experts to save a life. Bacteriophages are being considered an antibiotic replacement. Viruses are employed in this therapy to inject their genetic material into bacteria and grow using their host machinery. This phage therapy is utilized in the body of patients to cure or prevent bacterial diseases. Bacteriophage therapy is also important in the disciplines of molecular biology and technological research. These characteristics broaden the possibility for medication development. Bacteriophages are also termed as Phages.

Some of the major players operating in the bacteriophages therapy market are:

Microgen (U.S.)

Micreos (Netherlands)

ATCC (U.S.)

Intralytix, Inc. (U.S.)

Adaptive Phage Therapeutics (U.S.)

Armata pharmaceuticals Inc. (U.S.)

LOCUS BIOSCIENCES, INC. (U.S.)

Delmont Laboratories, Inc. (U.S.)

Nextbiotics (U.S.)

Pherecydes Pharma (France)

iNtODEWORLD. Inc. (U.S.)

Enbiotix (U.S.)

Fixed-Phage Limited (U.K.)

Cytophage Technologies Inc. (Canada)

Eliava Bio Preparations LTD (Georgia)

Phagelux, Inc. (China)

InnoPhage, Ltd (Hong Kong)

TechnoPhage (Portugal)

Eligo Bioscience SA (France)

BiomX Ltd. (Israel)

Drivers

High prevalence rate of foodborne diseases

The rise in prevalence rate of foodborne diseases across the globe will act as a major driver that will result in the expansion of the market's growth rate. Foodborne infections caused by spoiled food are becoming more common. Pathogenic bacteria and viruses are present in spoiled food. According to the WHO, about 600 million people (almost one out of every ten people on the planet) will become ill and 420,000 will die as a result of contaminated food in 2019, resulting in the loss of 33 million healthy life years (DALYs). Furthermore, children under the age of five years bear 40% of the burden of foodborne disease, with 125,000 deaths every year. This aspect is propelling the bacteriophages therapy market forward.

Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of bacteriophages therapy market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

Explore More Reports:

https://manoj-mrr.blogspot.com/2024/03/thermoplastic-micro-molding-market-to.html

https://manoj-mrr.blogspot.com/2024/03/synthetic-compressor-oil-market-will.html

https://manoj-mrr.blogspot.com/2024/03/sustainable-air-filters-market-will.html

https://manoj-mrr.blogspot.com/2024/03/surgical-blade-market-to-undergo-cagr.html

About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

Contact Us:
Data Bridge Market Research
Tel: +1-888-389.80-2818 | +44 208 089 1725 | +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com

This release was published on openPR.